2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Emerging Modalities
Tailwinds in cell and gene therapy development across Asia have necessitated new strategies for commercialization of these innovative treatments in various global markets.
How Pinotbio Is Helping Build Korea's ADC Ecosystem
Pinotbio CEO Dooyoung Jung shares his views on the Korean ADC industry’s situation and efforts needed for the sector to grow, the strengths of his company's camptothecin-based platform and pipeline, and R&D and business strategies.
